Literature DB >> 10589315

Syringe vending machines for injection drug users: an experiment in Marseille, France.

Y Obadia1, I Feroni, V Perrin, D Vlahov, J P Moatti.   

Abstract

OBJECTIVES: This study evaluated the usefulness of vending machines in providing injection drug users with access to sterile syringes in Marseille, France.
METHODS: Self-administered questionnaires were offered to 485 injection drug users obtaining syringes from 32 pharmacies, 4 needle exchange programs, and 3 vending machines.
RESULTS: Of the 343 respondents (response rate = 70.7%), 21.3% used the vending machines as their primary source of syringes. Primary users of vending machines were more likely than primary users of other sources to be younger than 30 years, to report no history of drug maintenance treatment, and to report no sharing of needles or injection paraphernalia.
CONCLUSIONS: Vending machines may be an appropriate strategy for providing access to syringes for younger injection drug users, who have typically avoided needle exchange programs and pharmacies.

Mesh:

Year:  1999        PMID: 10589315      PMCID: PMC1509009          DOI: 10.2105/ajph.89.12.1852

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  9 in total

1.  Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study.

Authors:  A Nicolosi; M L Leite; M Musicco; S Molinari; A Lazzarin
Journal:  Am J Epidemiol       Date:  1992-02-01       Impact factor: 4.897

2.  Single-use syringes.

Authors:  M E Samuels; C E Koop; P I Hartsock
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

3.  Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.

Authors:  L Wright-De Agüero; B Weinstein; T S Jones; J Miles
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

4.  Prevention of HIV/AIDS and other blood-borne diseases among injection drug users. A national survey on the regulation of syringes and needles.

Authors:  L O Gostin; Z Lazzarini; T S Jones; K Flaherty
Journal:  JAMA       Date:  1997-01-01       Impact factor: 56.272

5.  Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

Authors:  R S Garfein; D Vlahov; N Galai; M C Doherty; K E Nelson
Journal:  Am J Public Health       Date:  1996-05       Impact factor: 9.308

Review 6.  Economic analysis of needle exchange.

Authors:  E H Kaplan
Journal:  AIDS       Date:  1995-10       Impact factor: 4.177

7.  Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md.

Authors:  K E Nelson; D Vlahov; L Solomon; S Cohn; A Muñoz
Journal:  Arch Intern Med       Date:  1995-06-26

8.  Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law.

Authors:  P Case; G A Beckett; T S Jones
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

9.  Prevalence and incidence of hepatitis C virus infection among young adult injection drug users.

Authors:  R S Garfein; M C Doherty; E R Monterroso; D L Thomas; K E Nelson; D Vlahov
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998
  9 in total
  17 in total

1.  Characteristics and utilization patterns of needle-exchange attendees in Chicago: 1994-1998.

Authors:  H Brahmbhatt; D Bigg; S A Strathdee
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

2.  The role of epidemiology in needle exchange programs.

Authors:  D Des Vlahov
Journal:  Am J Public Health       Date:  2000-09       Impact factor: 9.308

3.  Optimal placement of syringe-exchange programs.

Authors:  Amy Welton; Kurt Adelberger; Ken Patterson; David Gilbert
Journal:  J Urban Health       Date:  2004-06       Impact factor: 3.671

4.  Effects of race, neighborhood, and social network on age at initiation of injection drug use.

Authors:  Crystal M Fuller; Luisa N Borrell; Carl A Latkin; Sandro Galea; Danielle C Ompad; Steffanie A Strathdee; David Vlahov
Journal:  Am J Public Health       Date:  2005-04       Impact factor: 9.308

Review 5.  Syringe availability as HIV prevention: a review of modalities.

Authors:  P Coffin
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

6.  Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.

Authors:  Sigrid Vorobjov; Anneli Uusküla; Katri Abel-Ollo; Ave Talu; Don Des Jarlais
Journal:  J Urban Health       Date:  2009-11-18       Impact factor: 3.671

7.  Exploring stakeholder perceptions of acceptability and feasibility of needle exchange programmes, syringe vending machines and safer injection facilities in Tijuana, Mexico.

Authors:  Morgan M Philbin; Andrea Mantsios; Remedios Lozada; Patricia Case; Robin A Pollini; Jorge Alvelais; Carl A Latkin; Carlos Magis-Rodriguez; Steffanie A Strathdee
Journal:  Int J Drug Policy       Date:  2008-10-28

8.  A cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011.

Authors:  Phillip L Marotta; Charlotte A McCullagh
Journal:  Int J Drug Policy       Date:  2016-02-26

9.  Assessing the role of syringe dispensing machines and mobile van outlets in reaching hard-to-reach and high-risk groups of injecting drug users (IDUs): a review.

Authors:  Md Mofizul Islam; Katherine M Conigrave
Journal:  Harm Reduct J       Date:  2007-10-24

10.  Acceptability of using electronic vending machines to deliver oral rapid HIV self-testing kits: a qualitative study.

Authors:  Sean D Young; Joseph Daniels; ChingChe J Chiu; Robert K Bolan; Risa P Flynn; Justin Kwok; Jeffrey D Klausner
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.